Legal status · United Kingdom
Is Lixisenatide legal in the United Kingdom?
Yes. Lixisenatide is an approved medicine in the United Kingdom, classified as "Licensed, prescription only (MHRA)". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Lixisenatide in the United Kingdom at a glance
| Classification | Licensed, prescription only (MHRA) |
|---|---|
| MHRA approval status | Approved by MHRA for its labeled use |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Lixisenatide profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
MHRA has approved Lixisenatide for at least one labeled indication, so a pharmaceutical-grade product exists in the United Kingdom and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Lixisenatide is
An FDA-approved once-daily GLP-1 receptor agonist for type 2 diabetes, also studied for effects beyond glucose control.
Lixisenatide is a once-daily GLP-1 receptor agonist derived from exendin-4, approved for type 2 diabetes as Adlyxin. It particularly targets post-meal glucose through pronounced slowing of gastric emptying.
Mechanism: Activates the GLP-1 receptor, enhancing glucose-dependent insulin release and markedly slowing gastric emptying to blunt post-meal glucose.
Regulatory history: FDA-approved (Adlyxin)
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Lixisenatide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Lixisenatide in other countries
Frequently asked questions
Is Lixisenatide legal in the United Kingdom?
Yes. Lixisenatide is an approved medicine in the United Kingdom, classified as "Licensed, prescription only (MHRA)". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Can I buy Lixisenatide in the United Kingdom?
Only with a prescription. Lixisenatide is classified as "Licensed, prescription only (MHRA)" in the United Kingdom, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Lixisenatide MHRA approved?
Yes, for its labeled indication. In the United Kingdom Lixisenatide is classified as "Licensed, prescription only (MHRA)". For comparison, the US FDA status is: FDA-approved (Adlyxin). Evidence level: Strong.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Lixisenatide live on its compound profile.
Lixisenatide profileThis page is general information about the regulatory status of Lixisenatide in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.